MTHFR and hyperhomocysteinemia: While the clinical significance of MTHFR polymorphisms (particularly C677T) remains controversial, they may contribute to hyperhomocysteinemia, especially in the presence of folate deficiency, thereby modestly increasing thrombotic risk [9].